Physician profile
Nicole M Fields
NPI 1851542468
$664.23
in general payments reported to CMS, 2019-2025
12 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.33 · 2020: $13.84 · 2022: $32.92 · 2023: $215 · 2024: $178 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $180.00 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $132.90 | 2025 | |
| Pfizer INC. | $52.42 | 2019-2024 | |
| Verrica Pharmaceuticals INC. | $47.87 | 2023-2024 | Ycanth |
| Merck Sharp & Dohme LLC | $47.16 | 2020-2023 | Vaxelis, Gardasil 9, M-M-R II |
| Kowa Pharmaceuticals America, INC. | $39.76 | 2024 | Zoryve |
| Sanofi Pasteur INC. | $39.71 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $38.20 | 2023 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $25.58 | 2023 | Flumist Quadrivalent |
| Biomarin Pharmaceutical INC. | $21.30 | 2023 | Voxzogo 1.2mg |
| Hologic Sales and Service, LLC | $20.29 | 2023 | Aptima |
| Tris Pharma INC | $19.04 | 2023 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.